Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
17
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 29 publications
4
17
1
Order By: Relevance
“…Increased levels of neopterin have been reported in various clinical disorders, including several autoimmune diseases. The significant elevation of serum levels of neopterin in DM patients observed in our study are in agreement with previously published studies [16,17,19,28]. In addition, we found that serum levels of neopterin correlated with disease activity in DM patients, as previously reported in juvenile myositis patients [17,18].…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Increased levels of neopterin have been reported in various clinical disorders, including several autoimmune diseases. The significant elevation of serum levels of neopterin in DM patients observed in our study are in agreement with previously published studies [16,17,19,28]. In addition, we found that serum levels of neopterin correlated with disease activity in DM patients, as previously reported in juvenile myositis patients [17,18].…”
Section: Discussionsupporting
confidence: 93%
“…Moreover, De Benedetti revealed that serum neopterin was significantly correlated with the severity of muscle strength impairment in juvenile DM . More recently, Nishioka found elevated serum neopterin may correlate with interstitial lung disease in anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis (CADM) . However, with increased understanding of the heterogeneous nature of DM, the clinical significance of neopterin in DM remains to be fully clarified and there is a paucity of longitudinal data concerning serum neopterin in relation to the outcome of DM patients.…”
Section: Introductionmentioning
confidence: 99%
“…Several other laboratory markers which are generally assessed in routine blood exams can be used as biomarkers. Among those are KL-6, ferritin, and troponins: KL-6 has been shown to be useful biomarkers for monitoring activity and severity of ILD in DM and PM as well as in jDM (32, 33). Ferritin was analyzed as a biomarker with similar profile as KL-6 and correlates well with treatment responsivity, specifically in anti-MDA5-associated DM (34, 35).…”
Section: Muscle Enzymes and Related Molecules As Biomarkersmentioning
confidence: 99%
“…Cross-section analysis showed that Serum sIL-2R levels had good correlation with disease activity as represented by MYOACT and physician VAS scores. Serum sIL-2R could be influenced by treatment [31]. Gottfried et al [32] found elevation of sIL-2R levels in DM patients and reverted to normal after response to IVIG treatment.…”
Section: Discussionmentioning
confidence: 99%